|
Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
OCA - Oceania Healthcare launches secured fixed rate bond offer
ATM - a2MC receives SAMR approval
June 22nd Morning Report
SPG - Retirement of Director Michelle Tierney
APL - AGM Date and Director Nominations
SKC - Resolution of Adelaide Independent Review
CMC Markets accredited as NZX Participant
June 18th Morning Report
PCT - Sale of PwC Tower to New Investment Partnership
MEL - Waitaki reconsenting receives final approval